ACADIA Pharmaceuticals
ACAD
#4034
Rank
โ‚น274.03 B
Marketcap
โ‚น1,586
Share price
-2.73%
Change (1 day)
-24.88%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2026 (TTM): โ‚น194.12

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น197.39. In 2025 the company made an earnings per share (EPS) of โ‚น214.99 an increase over its 2024 EPS that were of โ‚น126.03.

EPS history for ACADIA Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น194.12-9.71%
2025โ‚น214.9970.59%
2024โ‚น126.03-457.89%
2023-โ‚น35.21-71.64%
2022-โ‚น124.1827.62%
2021-โ‚น97.30-41.67%
2020-โ‚น166.8112.5%
2019-โ‚น148.27-17.95%
2018-โ‚น180.71-17.02%
2017-โ‚น217.770.43%
2016-โ‚น216.8543.56%
2015-โ‚น151.0573.4%
2014-โ‚น87.11
2012-โ‚น34.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น619.02 213.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น65.80-66.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,863 1,350.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น418.87 112.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-โ‚น428.14-316.90%๐Ÿ‡บ๐Ÿ‡ธ USA